Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Zhejiang Jiuzhou Pharm
ISIN CNE100001W36
|WKN A14TKV
Market cap (in EUR)
2,058 m
Country
China
Sector
Healthcare
Dividend yield
2.65%
Overview
Description
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. Its products include Carbamazepine, Oxcarbazepine, Duloxetine, Amprolium, Sulphadimethoxine, Sulphadimethoxine Sodium, Sulfasalazine, Bezafibrate, Ketoprofen, Gliclazide, Imipenem, Meropenem, Duloxetine and Pregabalin. The company was founded by Xuan De Hua on July 13, 1998 and is headquartered in Taizhou, China.
Healthcare Healthcare Services Outsourced Development and Manufacturing Services China
Financials
Key metrics
| Market capitalisation, EUR | 2,058 m |
| EPS, EUR | 0.10 |
| P/B ratio | 1.9 |
| P/E ratio | 23.0 |
| Dividend yield | 2.65% |
Income statement (2024)
| Revenue, EUR | 656 m |
| Net income, EUR | 78 m |
| Profit margin | 11.87% |
What ETF is Zhejiang Jiuzhou Pharm in?
There are 13 ETFs which contain Zhejiang Jiuzhou Pharm. All of these ETFs are listed in the table below. The ETF with the largest weighting of Zhejiang Jiuzhou Pharm is the Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.